MTST.US MetaStat Inc

Healthcare Life Sciences Tools & Services USA Stocks
0.0007 USD
Close of Oct 23, 2026
0.0003 0.0010
Market cap
USD 4.11K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Feb 2023.

Is MTST.US undervalued?

Graham number

The Graham number of MetaStat Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

MetaStat Inc fundamental analysis

No fundamental analysis for MetaStat Inc yet.

MetaStat Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About MetaStat Inc

MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK …

Full company profile